Scientific Program Evaluations Program Date: Wednesday, August 7, 2024 Please help us evaluate our speakers and the CGC 2024 Annual Meeting by answering a few questions below. We will have an evaluation form for each session and appreciate your time to give us your feedback. All evaluations are anonymous.

Please note, name and email address are required as part of the attendance verification for P.A.C.E. credit. Please be sure to list your name as it should appear when submitting P.A.C.E. credit.
Integrated comprehensive genomic profiling of meningiomas: A single institutional study
Mohana Priya Jayavel, Northwestern Memorial Hospital



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Significant copy number variants and loss of heterozygosity in Wilms Tumor: Insights from Nationwide Pediatric Oncology
Melanie Babcock, Nationwide Children's Hospital and The Ohio State University



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
The clinical utility of the TSO500 clinically-verified test in patients with solid tumors - The Mayo Clinic experience
Hussam Al Kateb, Mayo Clinic 



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Formation of a tumor-specific gene list: the Central Nervous System (CNS) tumor taskforce experience
Madina Sukhanova, Feinberg School of Medicine Northwestern University



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A

Modifying cancer variant interpretation guidelines for the curation of histone H3 variants - the 'next step' of the Cl
Laveniya Satgunaseelan, Royal Prince Alfred Hospital




1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Prioritization of defining and supportive diagnostic variants in pediatric tumors
Laura Corson, Oncology Consultant



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Step 2 updates for the Oncogenic assessment of FLT3 Variants by the ClinGen FLT3 Somatic Cancer Variant Curation expert
Nathan Kopp, Medical College of Wisconsin



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Piloting NTRK fusion-specific oncogenicity guidelines: Lessons learned
Jason Saliba, Washington University School of Medicine



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A

Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation
Alexa Dickson, Washington University in St Louis




1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
UMI-based expanded NGS panel in precision molecular diagnosis of vascular anomalies: Early results
Avinash Dharmadhikari, Children's Hospital Los Angeles



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Examining potential candidate genes within deletions of 3p14.2 to 3p14.1 in two cases of autism and developmental delay
Rebecca Smith, Vanderbilt University Medical Center



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
Clinical SNP-array adds value to diagnosis and surveillance of bone marrow failure syndromes
Lucilla Pizzo, University of Utah, ARUP Laboratories



1

2

3

4

5

N/A



1

2

3

4

5

N/A



1

2

3

4

5

N/A
By submitting your data you give us your consent to process it in accordance with our Privacy Policy